| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC2A9 SLC37A3 SLC16A9 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 SLCO1B1 SLC5A5 SLC17A5 SLC10A2 SLCO4C1 SLC16A5 SLC16A4 SLC41A3 SLC34A1 SLC18A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC16A7 SLC37A4 SLC16A10 | 8.00e-23 | 296 | 123 | 26 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP6V1A SLC2A9 SLC37A3 SLC16A9 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 SLCO1B1 ABCA9 SLC5A5 SLC17A5 SLC10A2 SLCO4C1 SLC16A5 SLC16A4 SLC41A3 SLC34A1 SLC18A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC16A7 SLC37A4 SLC16A10 | 8.41e-20 | 477 | 123 | 28 | GO:0022804 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC37A3 SLC16A9 SLCO2B1 SLCO4A1 SLC26A9 SLCO1B3 SLCO1B1 SLC17A5 SLC10A2 SLCO4C1 SLC16A5 SLC16A4 SLCO2A1 SLC5A6 SLC4A10 SLC25A29 SLC16A7 SLC37A4 MFSD10 SLC16A10 | 1.45e-15 | 293 | 123 | 20 | GO:0008514 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP6V1A SLC2A9 SLC37A3 SLC16A9 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 APOL1 SLCO1B1 ABCA9 SLC39A13 SLC2A5 SLC5A5 SLC41A2 SLC17A5 SLC10A2 SLCO4C1 SLC16A5 SLC16A4 SLC41A3 SLC34A1 SLC18A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC49A3 SLC25A29 SLC16A7 SLC37A4 MFSD10 SLC16A10 | 2.52e-15 | 1180 | 123 | 35 | GO:0022857 |
| GeneOntologyMolecularFunction | symporter activity | SLC2A9 SLC16A9 SLC6A19 SLC24A3 SLC5A5 SLC17A5 SLC10A2 SLC16A5 SLC16A4 SLC34A1 SLC18A1 SLC5A6 SLC22A4 SLC4A10 SLC16A7 | 2.35e-14 | 150 | 123 | 15 | GO:0015293 |
| GeneOntologyMolecularFunction | transporter activity | ATP6V1A SLC2A9 SLC37A3 SLC16A9 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 APOL1 SLCO1B1 ABCA9 SLC39A13 SLC2A5 SLC5A5 SLC41A2 SLC17A5 SLC10A2 SLCO4C1 SLC16A5 SLC16A4 SLC41A3 SLC34A1 SLC18A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC49A3 SLC25A29 SLC16A7 SLC37A4 MFSD10 SLC16A10 | 3.54e-14 | 1289 | 123 | 35 | GO:0005215 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | SLC16A9 SLCO2B1 SLCO1B3 SLCO1B1 SLC10A2 SLC16A5 SLC16A4 SLC5A6 SLC16A7 SLC16A10 | 2.05e-10 | 90 | 123 | 10 | GO:0008028 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC16A9 SLCO2B1 SLC26A9 SLCO1B3 SLCO1B1 SLC17A5 SLC10A2 SLC16A5 SLC16A4 SLC5A6 SLC25A29 SLC16A7 SLC16A10 | 4.94e-10 | 207 | 123 | 13 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC16A9 SLCO2B1 SLC26A9 SLCO1B3 SLCO1B1 SLC17A5 SLC10A2 SLC16A5 SLC16A4 SLC5A6 SLC25A29 SLC16A7 SLC16A10 | 5.25e-10 | 208 | 123 | 13 | GO:0005342 |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 8.44e-10 | 18 | 123 | 6 | GO:0015347 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 1.56e-08 | 14 | 123 | 5 | GO:0015132 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.34e-08 | 15 | 123 | 5 | GO:0071714 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 OR2H2 | 6.75e-08 | 431 | 123 | 15 | GO:0004984 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.46e-07 | 70 | 123 | 7 | GO:1901618 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP6V1A SLC2A9 SLC26A9 SLC24A3 SLC5A5 SLC17A5 SLC10A2 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC4A10 | 3.58e-07 | 301 | 123 | 12 | GO:0022853 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TBXA2R CMKLR2 OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 ADGRL1 OR14I1 CCKBR OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 OR2H2 | 4.54e-07 | 884 | 123 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC2A9 SLC5A5 SLC17A5 SLC10A2 SLC34A1 SLC18A1 SLC5A6 SLC4A10 | 7.30e-07 | 119 | 123 | 8 | GO:0015294 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | SLC37A3 SLC26A9 APOL1 SLC5A5 SLC34A1 SLC18A1 SLC5A6 SLC4A10 SLC37A4 | 1.14e-06 | 171 | 123 | 9 | GO:0015103 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TBXA2R CMKLR2 OR4N2 OR9G1 OR2T27 OR4N4 HLA-DQB1 OR2T7 OR10Q1 NRG2 OR2T1 ADGRL1 OR14I1 CCKBR OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 NRXN1 OR52A5 OR7D2 TLR5 OR2H2 | 2.25e-06 | 1353 | 123 | 24 | GO:0004888 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP6V1A SLC2A9 SLC37A3 SLC26A9 SLC24A3 APOL1 SLC39A13 SLC5A5 SLC41A2 SLC17A5 SLC10A2 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC4A10 SLC37A4 | 4.08e-06 | 758 | 123 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 5.87e-06 | 73 | 123 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.08e-05 | 81 | 123 | 6 | GO:0015370 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC24A3 SLC5A5 SLC10A2 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC4A10 | 1.10e-05 | 171 | 123 | 8 | GO:0015081 |
| GeneOntologyMolecularFunction | thyroid hormone transmembrane transporter activity | 1.86e-05 | 9 | 123 | 3 | GO:0015349 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.36e-05 | 138 | 123 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 4.31e-05 | 32 | 123 | 4 | GO:0005452 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.51e-05 | 34 | 123 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 9.83e-05 | 15 | 123 | 3 | GO:0015651 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP6V1A SLC2A9 SLC26A9 SLC24A3 APOL1 SLC39A13 SLC5A5 SLC41A2 SLC17A5 SLC10A2 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC4A10 | 1.10e-04 | 793 | 123 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | 15-oxoprostaglandin 13-oxidase [NAD(P)+] activity | 1.12e-04 | 3 | 123 | 2 | GO:0047522 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP6V1A SLC2A9 SLC24A3 SLC39A13 SLC5A5 SLC41A2 SLC17A5 SLC10A2 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC4A10 | 1.32e-04 | 627 | 123 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 2.06e-04 | 19 | 123 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.15e-04 | 196 | 123 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | hexose-phosphate:phosphate antiporter activity | 2.24e-04 | 4 | 123 | 2 | GO:0015526 | |
| GeneOntologyMolecularFunction | hexose phosphate transmembrane transporter activity | 2.24e-04 | 4 | 123 | 2 | GO:0015119 | |
| GeneOntologyMolecularFunction | glucose-6-phosphate transmembrane transporter activity | 2.24e-04 | 4 | 123 | 2 | GO:0015152 | |
| GeneOntologyMolecularFunction | adipokinetic hormone receptor activity | 2.24e-04 | 4 | 123 | 2 | GO:0097003 | |
| GeneOntologyMolecularFunction | glucose 6-phosphate:phosphate antiporter activity | 2.24e-04 | 4 | 123 | 2 | GO:0061513 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP6V1A SLC2A9 SLC24A3 SLC39A13 SLC5A5 SLC41A2 SLC17A5 SLC10A2 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC4A10 | 2.32e-04 | 664 | 123 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 3.48e-04 | 151 | 123 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | iodide transmembrane transporter activity | 3.72e-04 | 5 | 123 | 2 | GO:0015111 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 3.72e-04 | 5 | 123 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 4.20e-04 | 24 | 123 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | carnitine transmembrane transporter activity | 5.55e-04 | 6 | 123 | 2 | GO:0015226 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 5.80e-04 | 62 | 123 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC24A3 SLC39A13 SLC5A5 SLC41A2 SLC10A2 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC4A10 | 6.13e-04 | 465 | 123 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | growth factor receptor binding | 7.14e-04 | 173 | 123 | 6 | GO:0070851 | |
| GeneOntologyMolecularFunction | organophosphate:phosphate antiporter activity | 7.75e-04 | 7 | 123 | 2 | GO:0015315 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 7.75e-04 | 7 | 123 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | carbohydrate:proton symporter activity | 1.03e-03 | 8 | 123 | 2 | GO:0005351 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 1.09e-03 | 33 | 123 | 3 | GO:0072349 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.19e-03 | 34 | 123 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | fructose transmembrane transporter activity | 1.32e-03 | 9 | 123 | 2 | GO:0005353 | |
| GeneOntologyMolecularFunction | guanylate cyclase activity | 1.64e-03 | 10 | 123 | 2 | GO:0004383 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.73e-03 | 83 | 123 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 2.20e-03 | 42 | 123 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 2.20e-03 | 42 | 123 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 2.35e-03 | 43 | 123 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 2.81e-03 | 13 | 123 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 2.81e-03 | 13 | 123 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 3.75e-03 | 15 | 123 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | glucosidase activity | 3.75e-03 | 15 | 123 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | hormone binding | 3.79e-03 | 103 | 123 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.06e-03 | 105 | 123 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 4.27e-03 | 16 | 123 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 4.74e-03 | 55 | 123 | 3 | GO:0017046 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 4.82e-03 | 17 | 123 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 5.40e-03 | 18 | 123 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | magnesium ion transmembrane transporter activity | 5.40e-03 | 18 | 123 | 2 | GO:0015095 | |
| GeneOntologyMolecularFunction | toxic substance binding | 5.40e-03 | 18 | 123 | 2 | GO:0015643 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 5.77e-03 | 59 | 123 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 6.01e-03 | 19 | 123 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.49e-03 | 125 | 123 | 4 | GO:0015108 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC2A9 SLC37A3 SLC16A9 SLCO2B1 ARL6IP5 SLCO4A1 SLC26A9 SLCO1B3 SLCO1B1 PTGS2 SLC17A5 SLC10A2 SLCO4C1 SLC16A5 SLC16A4 SLCO2A1 SLC5A6 SLC4A10 PLA2G4A SLC25A29 SLC16A7 SLC37A4 MFSD10 SLC16A10 | 5.21e-15 | 515 | 124 | 24 | GO:0015711 |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 1.48e-12 | 15 | 124 | 7 | GO:0043252 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | SLC16A9 SLCO2B1 SLCO4A1 SLCO1B3 SLCO1B1 PTGS2 SLC17A5 SLC10A2 SLC16A5 SLC16A4 SLCO2A1 SLC5A6 PLA2G4A SLC16A7 SLC16A10 | 2.92e-12 | 213 | 124 | 15 | GO:0015718 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC16A9 SLCO2B1 ARL6IP5 SLCO4A1 SLC26A9 SLCO1B3 SLCO1B1 PTGS2 SLC17A5 SLC10A2 SLC16A5 SLC16A4 SLCO2A1 SLC5A6 PLA2G4A SLC25A29 SLC16A7 SLC16A10 | 4.84e-11 | 410 | 124 | 18 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC16A9 SLCO2B1 ARL6IP5 SLCO4A1 SLC26A9 SLCO1B3 SLCO1B1 PTGS2 SLC17A5 SLC10A2 SLC16A5 SLC16A4 SLCO2A1 SLC5A6 PLA2G4A SLC25A29 SLC16A7 SLC16A10 | 5.24e-11 | 412 | 124 | 18 | GO:0015849 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 OR2H2 | 3.60e-08 | 485 | 124 | 16 | GO:0050907 |
| GeneOntologyBiologicalProcess | prostaglandin transport | 4.90e-08 | 34 | 124 | 6 | GO:0015732 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 OR2H2 | 5.11e-08 | 432 | 124 | 15 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 OR2H2 | 1.04e-07 | 524 | 124 | 16 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 OR2H2 | 1.33e-07 | 465 | 124 | 15 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 OR2H2 | 1.86e-07 | 547 | 124 | 16 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 OR2H2 | 4.28e-07 | 582 | 124 | 16 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 GUCY2D OR2H2 | 1.54e-06 | 722 | 124 | 17 | GO:0051606 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP6V1A SLC2A9 ANK2 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 APOL1 SLCO1B1 PTGS2 SLC39A13 SLC5A5 SLC41A2 SLC17A5 SLC10A2 SLCO4C1 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC22A4 SLC4A10 | 1.95e-06 | 1374 | 124 | 24 | GO:0006811 |
| GeneOntologyBiologicalProcess | icosanoid transport | 5.12e-06 | 73 | 124 | 6 | GO:0071715 | |
| GeneOntologyBiologicalProcess | sensory perception | NPR2 OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 GUCY2D SLC4A10 MYO15A OR2H2 | 6.03e-06 | 1072 | 124 | 20 | GO:0007600 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.34e-05 | 180 | 124 | 8 | GO:0015698 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.67e-05 | 134 | 124 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | carnitine transport | 1.74e-05 | 9 | 124 | 3 | GO:0015879 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | TBXA2R CMKLR2 OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 ADGRL1 OR14I1 CCKBR OR9G9 OR11H6 OR3A2 OR6F1 DEFB4A TAS2R9 OR52A5 OR7D2 GUCY2D OR2H2 | 2.75e-05 | 1395 | 124 | 22 | GO:0007186 |
| GeneOntologyBiologicalProcess | pigment catabolic process | 3.38e-05 | 11 | 124 | 3 | GO:0046149 | |
| GeneOntologyBiologicalProcess | heme catabolic process | 3.38e-05 | 11 | 124 | 3 | GO:0042167 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP6V1A SLC2A9 SLC37A3 ANK2 SLC6A19 SLC26A9 SLC24A3 APOL1 SLC39A13 SLC5A5 SLC41A2 SLC17A5 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC4A10 SLC37A4 | 3.72e-05 | 1017 | 124 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC6A19 SLC24A3 SLC5A5 SLC10A2 SLC41A3 SLC34A1 SLC5A6 SLC22A4 SLC4A10 | 4.36e-05 | 275 | 124 | 9 | GO:0006814 |
| GeneOntologyBiologicalProcess | thyroid hormone transport | 5.80e-05 | 13 | 124 | 3 | GO:0070327 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound catabolic process | 5.80e-05 | 13 | 124 | 3 | GO:0006787 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 7.35e-05 | 14 | 124 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | amino-acid betaine transport | 7.35e-05 | 14 | 124 | 3 | GO:0015838 | |
| GeneOntologyBiologicalProcess | phosphate ion transmembrane transport | 9.15e-05 | 15 | 124 | 3 | GO:0035435 | |
| GeneOntologyBiologicalProcess | iodide transmembrane transport | 1.07e-04 | 3 | 124 | 2 | GO:1904200 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 1.40e-04 | 44 | 124 | 4 | GO:0072337 | |
| GeneOntologyBiologicalProcess | fatty acid transport | 1.48e-04 | 132 | 124 | 6 | GO:0015908 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.80e-04 | 87 | 124 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.82e-04 | 47 | 124 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.90e-04 | 88 | 124 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | quaternary ammonium group transport | 1.92e-04 | 19 | 124 | 3 | GO:0015697 | |
| GeneOntologyBiologicalProcess | lipid transport | SLCO2B1 SLCO4A1 SLCO1B3 APOL1 SLCO1B1 ABCA9 PTGS2 SLC10A2 SLCO2A1 PLA2G4A SOAT1 | 2.43e-04 | 506 | 124 | 11 | GO:0006869 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.66e-04 | 208 | 124 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 3.59e-04 | 56 | 124 | 4 | GO:0006693 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 3.84e-04 | 57 | 124 | 4 | GO:0006692 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 4.60e-04 | 163 | 124 | 6 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 5.23e-04 | 167 | 124 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP6V1A SLC2A9 ANK2 SLC6A19 SLC24A3 PTGS2 SLC39A13 SLC5A5 SLC41A2 SLC17A5 SLC10A2 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC22A4 SLC4A10 | 5.63e-04 | 1157 | 124 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | lipid localization | SLCO2B1 SLCO4A1 SLCO1B3 APOL1 SLCO1B1 ABCA9 PTGS2 SLC10A2 SLCO2A1 PLA2G4A SOAT1 | 6.13e-04 | 565 | 124 | 11 | GO:0010876 |
| GeneOntologyBiologicalProcess | hexose phosphate transport | 7.38e-04 | 7 | 124 | 2 | GO:0015712 | |
| GeneOntologyBiologicalProcess | glucose-6-phosphate transport | 7.38e-04 | 7 | 124 | 2 | GO:0015760 | |
| GeneOntologyBiologicalProcess | carnitine transmembrane transport | 7.38e-04 | 7 | 124 | 2 | GO:1902603 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 7.95e-04 | 120 | 124 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 8.43e-04 | 31 | 124 | 3 | GO:0006817 | |
| GeneOntologyBiologicalProcess | regulation of synapse maturation | 8.43e-04 | 31 | 124 | 3 | GO:0090128 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 8.45e-04 | 183 | 124 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP6V1A SLC2A9 ANK2 SLC6A19 SLC26A9 SLC24A3 APOL1 SLC39A13 SLC5A5 SLC41A2 SLC17A5 SLC41A3 SLC34A1 SLC18A1 SLC5A6 SLC4A10 | 1.06e-03 | 1115 | 124 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | thyroid hormone metabolic process | 1.11e-03 | 34 | 124 | 3 | GO:0042403 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC2A9 ANK2 SLCO2B1 SLCO4A1 SLCO1B3 SLCO1B1 TGFA SLC17A5 SLCO4C1 SLC16A5 SLC34A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC16A7 SLC16A10 | 3.53e-11 | 354 | 124 | 17 | GO:0009925 |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC2A9 ANK2 SLCO2B1 SLCO4A1 SLCO1B3 SLCO1B1 TGFA SLC17A5 SLCO4C1 SLC16A5 SLC34A1 SLCO2A1 SLC5A6 SLC4A10 SLC16A7 SLC16A10 | 7.66e-11 | 320 | 124 | 16 | GO:0016323 |
| GeneOntologyCellularComponent | basal part of cell | SLC2A9 ANK2 SLCO2B1 SLCO4A1 SLCO1B3 SLCO1B1 TGFA SLC17A5 SLCO4C1 SLC16A5 SLC34A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC16A7 SLC16A10 | 9.80e-11 | 378 | 124 | 17 | GO:0045178 |
| GeneOntologyCellularComponent | apical plasma membrane | ATP6V1A SLC2A9 ANK2 DSG1 SLCO2B1 SLC6A19 SLC26A9 SI SLC2A5 SLC10A2 SLC34A1 SLC5A6 SLC22A4 PKHD1 SLC4A10 | 2.03e-07 | 487 | 124 | 15 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | ATP6V1A SLC2A9 ANK2 DSG1 SLCO2B1 SLC6A19 SLC26A9 SI SLC2A5 SLC10A2 SLC34A1 SLC5A6 SLC22A4 PKHD1 SLC4A10 | 2.35e-06 | 592 | 124 | 15 | GO:0045177 |
| HumanPheno | Hyperbilirubinemia | 2.32e-05 | 130 | 48 | 8 | HP:0002904 | |
| HumanPheno | Conjugated hyperbilirubinemia | 2.39e-05 | 38 | 48 | 5 | HP:0002908 | |
| HumanPheno | Abnormal circulating bilirubin concentration | 2.45e-05 | 131 | 48 | 8 | HP:0033479 | |
| HumanPheno | Conjunctival icterus | 2.68e-05 | 7 | 48 | 3 | HP:0032106 | |
| HumanPheno | Fat malabsorption | 4.22e-05 | 70 | 48 | 6 | HP:0002630 | |
| HumanPheno | Malabsorption | DSG1 HLA-DQB1 SLC6A19 SLC26A9 SI LBR HSD3B7 SLC10A2 SLCO2A1 PKHD1 | 5.01e-05 | 235 | 48 | 10 | HP:0002024 |
| HumanPheno | Bilirubinuria | 8.70e-05 | 2 | 48 | 2 | HP:0031811 | |
| Domain | MFS_dom | SLC2A9 SLC37A3 SLC16A9 SLCO2B1 MFSD11 SLCO4A1 SLCO1B3 SLCO1B1 SLC2A5 SLC17A5 SLCO4C1 SLC16A5 SLC16A4 SLC18A1 SLCO2A1 SLC22A4 SLC49A3 SLC16A7 SLC37A4 MFSD10 SLC16A10 | 1.72e-23 | 134 | 121 | 21 | IPR020846 |
| Domain | MFS | SLC2A9 SLC37A3 SLC16A9 SLCO4A1 SLCO1B3 SLCO1B1 SLC2A5 SLC17A5 SLCO4C1 SLC16A5 SLC16A4 SLC18A1 SLCO2A1 SLC22A4 SLC49A3 SLC16A7 SLC37A4 MFSD10 SLC16A10 | 2.47e-22 | 108 | 121 | 19 | PS50850 |
| Domain | MFS_1 | SLC37A3 SLC16A9 SLC17A5 SLC16A5 SLC16A4 SLC18A1 SLC22A4 SLC49A3 SLC16A7 SLC37A4 MFSD10 SLC16A10 | 8.07e-14 | 77 | 121 | 12 | PF07690 |
| Domain | MFS | SLC37A3 SLC16A9 SLC17A5 SLC16A5 SLC16A4 SLC18A1 SLC22A4 SLC49A3 SLC16A7 SLC37A4 MFSD10 SLC16A10 | 8.07e-14 | 77 | 121 | 12 | IPR011701 |
| Domain | OA_transporter | 5.84e-11 | 12 | 121 | 6 | IPR004156 | |
| Domain | OATP | 5.84e-11 | 12 | 121 | 6 | PF03137 | |
| Domain | Olfact_rcpt | OR4N2 OR9G1 OR2T27 OR4N4 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 OR2H2 | 2.60e-07 | 393 | 121 | 14 | IPR000725 |
| Domain | GPCR_Rhodpsn_7TM | TBXA2R CMKLR2 OR4N2 OR9G1 OR2T27 OR4N4 OR10Q1 OR2T1 OR14I1 CCKBR OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 OR2H2 | 3.12e-07 | 670 | 121 | 18 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_2 | TBXA2R CMKLR2 OR4N2 OR9G1 OR2T27 OR4N4 OR10Q1 OR2T1 OR14I1 CCKBR OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 OR2H2 | 4.89e-07 | 691 | 121 | 18 | PS50262 |
| Domain | GPCR_Rhodpsn | TBXA2R CMKLR2 OR4N2 OR9G1 OR2T27 OR4N4 OR10Q1 OR2T1 OR14I1 CCKBR OR9G9 OR11H6 OR3A2 OR6F1 TAS2R9 OR52A5 OR7D2 OR2H2 | 4.99e-07 | 692 | 121 | 18 | IPR000276 |
| Domain | KAZAL_2 | 8.22e-07 | 50 | 121 | 6 | PS51465 | |
| Domain | Kazal_dom | 9.26e-07 | 51 | 121 | 6 | IPR002350 | |
| Domain | 7tm_1 | TBXA2R CMKLR2 OR4N2 OR9G1 OR2T27 OR4N4 OR10Q1 OR2T1 OR14I1 CCKBR OR9G9 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 OR2H2 | 1.73e-06 | 677 | 121 | 17 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | TBXA2R CMKLR2 OR4N2 OR9G1 OR2T27 OR4N4 OR10Q1 OR2T1 OR14I1 CCKBR OR9G9 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 OR2H2 | 2.03e-06 | 685 | 121 | 17 | PS00237 |
| Domain | Kazal_2 | 3.37e-06 | 36 | 121 | 5 | PF07648 | |
| Domain | - | 1.24e-04 | 3 | 121 | 2 | 1.10.357.20 | |
| Domain | MgtE | 1.24e-04 | 3 | 121 | 2 | PF01769 | |
| Domain | DUF2371_TMEM200 | 1.24e-04 | 3 | 121 | 2 | IPR018787 | |
| Domain | SLC41_membr_dom | 1.24e-04 | 3 | 121 | 2 | IPR006667 | |
| Domain | DUF2371 | 1.24e-04 | 3 | 121 | 2 | PF10177 | |
| Domain | KAZAL | 2.22e-04 | 46 | 121 | 4 | SM00280 | |
| Domain | Sugar_P_transporter | 2.48e-04 | 4 | 121 | 2 | IPR000849 | |
| Domain | NtCtMGAM_N | 2.48e-04 | 4 | 121 | 2 | PF16863 | |
| Domain | Gal_mutarotase_N | 2.48e-04 | 4 | 121 | 2 | IPR031727 | |
| Domain | MCT | 4.11e-04 | 5 | 121 | 2 | IPR004743 | |
| Domain | SUGAR_TRANSPORT_1 | 4.86e-04 | 24 | 121 | 3 | PS00216 | |
| Domain | Glyco_hydro_31_AS | 6.14e-04 | 6 | 121 | 2 | IPR030458 | |
| Domain | EGF_3 | 8.56e-04 | 235 | 121 | 7 | PS50026 | |
| Domain | EGF | 8.56e-04 | 235 | 121 | 7 | SM00181 | |
| Domain | Glyco_hydro_31 | 8.56e-04 | 7 | 121 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 8.56e-04 | 7 | 121 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 8.56e-04 | 7 | 121 | 2 | PS00129 | |
| Domain | Na/solute_symporter_CS | 1.14e-03 | 8 | 121 | 2 | IPR018212 | |
| Domain | Trefoil | 1.14e-03 | 8 | 121 | 2 | PF00088 | |
| Domain | Sugar_transporter_CS | 1.15e-03 | 32 | 121 | 3 | IPR005829 | |
| Domain | LRRCT | 1.15e-03 | 32 | 121 | 3 | PF01463 | |
| Domain | EGF-like_dom | 1.20e-03 | 249 | 121 | 7 | IPR000742 | |
| Domain | EGF_1 | 1.37e-03 | 255 | 121 | 7 | PS00022 | |
| Domain | EGF | 1.37e-03 | 126 | 121 | 5 | PF00008 | |
| Domain | P_TREFOIL_2 | 1.45e-03 | 9 | 121 | 2 | PS51448 | |
| Domain | PD | 1.45e-03 | 9 | 121 | 2 | SM00018 | |
| Domain | EGF-like_CS | 1.57e-03 | 261 | 121 | 7 | IPR013032 | |
| Domain | MFS_sugar_transport-like | 1.62e-03 | 36 | 121 | 3 | IPR005828 | |
| Domain | Sugar_tr | 1.62e-03 | 36 | 121 | 3 | PF00083 | |
| Domain | EGF_2 | 1.71e-03 | 265 | 121 | 7 | PS01186 | |
| Domain | - | 2.20e-03 | 11 | 121 | 2 | 4.10.110.10 | |
| Domain | NA_SOLUT_SYMP_1 | 2.20e-03 | 11 | 121 | 2 | PS00456 | |
| Domain | NA_SOLUT_SYMP_2 | 2.63e-03 | 12 | 121 | 2 | PS00457 | |
| Domain | SSF | 2.63e-03 | 12 | 121 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 2.63e-03 | 12 | 121 | 2 | IPR001734 | |
| Domain | P_trefoil_dom | 2.63e-03 | 12 | 121 | 2 | IPR000519 | |
| Domain | NA_SOLUT_SYMP_3 | 2.63e-03 | 12 | 121 | 2 | PS50283 | |
| Domain | Sugar/inositol_transpt | 3.60e-03 | 14 | 121 | 2 | IPR003663 | |
| Domain | Glycoside_hydrolase_SF | 4.91e-03 | 53 | 121 | 3 | IPR017853 | |
| Domain | Gal_mutarotase_SF_dom | 5.31e-03 | 17 | 121 | 2 | IPR011013 | |
| Domain | SUGAR_TRANSPORT_2 | 5.31e-03 | 17 | 121 | 2 | PS00217 | |
| Domain | A/G_cyclase_CS | 5.31e-03 | 17 | 121 | 2 | IPR018297 | |
| Domain | - | 5.95e-03 | 18 | 121 | 2 | 3.90.180.10 | |
| Domain | Nucleotide_cyclase | 5.95e-03 | 18 | 121 | 2 | IPR029787 | |
| Domain | - | 5.95e-03 | 18 | 121 | 2 | 3.30.70.1230 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A9 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 SLCO1B1 SLC5A5 SLC41A2 SLC17A5 SLCO4C1 SLC34A1 SLC18A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC25A29 SLC16A7 SLC16A10 | 9.91e-18 | 238 | 98 | 21 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A9 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 SLCO1B1 SLC5A5 SLC41A2 SLC17A5 SLCO4C1 SLC34A1 SLC18A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC25A29 SLC16A7 SLC16A10 | 2.52e-17 | 249 | 98 | 21 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6V1A SLC2A9 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 SLCO1B1 ABCA9 SLC5A5 SLC41A2 SLC17A5 SLCO4C1 SLC34A1 SLC18A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC25A29 SLC16A7 SOAT1 SLC16A10 | 2.73e-11 | 681 | 98 | 24 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 4.34e-11 | 11 | 98 | 6 | M930 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 8.64e-11 | 12 | 98 | 6 | MM15476 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6V1A SLC2A9 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 SLCO1B1 ABCA9 SLC5A5 SLC41A2 SLC17A5 SLCO4C1 SLC34A1 SLC18A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC25A29 SLC16A7 SOAT1 SLC16A10 | 1.36e-10 | 736 | 98 | 24 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.17e-08 | 41 | 98 | 7 | MM15075 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.66e-08 | 43 | 98 | 7 | M881 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | TPR SLC2A9 SLC6A19 SLCO1B3 SLCO1B1 SLC5A5 SLC17A5 SLC34A1 SLCO2A1 | 2.70e-08 | 99 | 98 | 9 | M27474 |
| Pathway | WP_SULFATASE_AND_AROMATASE_PATHWAY | 2.79e-08 | 14 | 98 | 5 | M48085 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC6A19 SLC26A9 SLC24A3 SLC5A5 SLC17A5 SLC34A1 SLC4A10 SLC25A29 SLC16A10 | 5.79e-08 | 108 | 98 | 9 | M823 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC6A19 SLC26A9 SLC24A3 SLC5A5 SLC17A5 SLC34A1 SLC4A10 SLC25A29 SLC16A10 | 6.28e-08 | 109 | 98 | 9 | MM15074 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 OR2H2 | 1.75e-07 | 417 | 98 | 15 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR4N2 OR9G1 OR2T27 OR4N4 OR10Q1 OR2T1 OR14I1 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 GUCY2D OR2H2 | 4.67e-07 | 389 | 98 | 14 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR14I1 OR9G9 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 GUCY2D MYO15A OR2H2 | 1.61e-06 | 636 | 98 | 17 | M41834 |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 2.16e-06 | 31 | 98 | 5 | M39851 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 2.98e-06 | 33 | 98 | 5 | MM15918 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | TPR SLC2A9 SLC6A19 SLCO1B3 SLCO1B1 SLC5A5 SLC17A5 SLC34A1 SLCO2A1 | 3.82e-06 | 177 | 98 | 9 | M27476 |
| Pathway | WP_NRF2_PATHWAY | 6.05e-06 | 141 | 98 | 8 | M39454 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | SLC2A9 SLCO2B1 SLC6A19 SLCO1B1 PTGS2 SLC39A13 SLC2A5 TGFA SLC5A5 PTGR1 SLC5A6 | 1.12e-05 | 314 | 98 | 11 | M39428 |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.65e-05 | 9 | 98 | 3 | M45020 | |
| Pathway | WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT | 4.56e-05 | 29 | 98 | 4 | M45551 | |
| Pathway | WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE | 4.61e-05 | 57 | 98 | 5 | M48332 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 4.61e-05 | 57 | 98 | 5 | M39812 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 6.85e-05 | 12 | 98 | 3 | M48096 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.40e-04 | 15 | 98 | 3 | M27060 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.40e-04 | 15 | 98 | 3 | MM15697 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.83e-04 | 76 | 98 | 5 | MM15072 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 2.41e-04 | 44 | 98 | 4 | M499 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 2.46e-04 | 18 | 98 | 3 | M4862 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 2.63e-04 | 45 | 98 | 4 | MM14751 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 2.91e-04 | 19 | 98 | 3 | MM14612 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.93e-04 | 84 | 98 | 5 | M27334 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 3.41e-04 | 20 | 98 | 3 | MM1529 | |
| Pathway | WP_LIPID_METABOLISM_IN_SENESCENT_CELLS | 3.41e-04 | 20 | 98 | 3 | M45542 | |
| Pathway | REACTOME_HEME_DEGRADATION | 3.41e-04 | 20 | 98 | 3 | MM14721 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 4.56e-04 | 22 | 98 | 3 | M22003 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 7.46e-04 | 59 | 98 | 4 | M27140 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 8.44e-04 | 27 | 98 | 3 | M1088 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.40e-03 | 32 | 98 | 3 | MM14719 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.40e-03 | 32 | 98 | 3 | MM14957 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.42e-03 | 70 | 98 | 4 | MM14984 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.53e-03 | 33 | 98 | 3 | M188 | |
| Pathway | REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM | 1.67e-03 | 34 | 98 | 3 | M27546 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.84e-03 | 126 | 98 | 5 | MM15553 | |
| Pathway | WP_EICOSANOID_LIPID_SYNTHESIS_MAP | 2.08e-03 | 10 | 98 | 2 | MM15916 | |
| Pubmed | 8.69e-13 | 11 | 125 | 6 | 14579113 | ||
| Pubmed | Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. | 3.07e-11 | 8 | 125 | 5 | 19129463 | |
| Pubmed | 1.08e-09 | 14 | 125 | 5 | 12739169 | ||
| Pubmed | Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier. | 2.34e-09 | 16 | 125 | 5 | 35307651 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | ACTR10 ARL6IP5 SLCO4A1 SI TIMMDC1 SLC39A13 CCKBR TMEM33 OSTC TM9SF2 SLC41A3 SLC5A6 CD37 SLC37A4 MFSD10 | 3.45e-08 | 697 | 125 | 15 | 28298427 |
| Pubmed | SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk. | 4.53e-08 | 3 | 125 | 3 | 24762081 | |
| Pubmed | Impact of regulatory polymorphisms in organic anion transporter genes in the human liver. | 4.53e-08 | 3 | 125 | 3 | 19620935 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 26409184 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 28013215 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 29422623 | ||
| Pubmed | Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III. | 4.53e-08 | 3 | 125 | 3 | 26383540 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 32587096 | ||
| Pubmed | SLC6A19 SLCO1B3 SLCO1B1 SLC2A5 SLC41A2 SLCO4C1 SLC34A1 SLC18A1 SLC16A10 | 8.13e-08 | 212 | 125 | 9 | 19521566 | |
| Pubmed | OR4N2 OR9G1 OR2T27 OR4N4 OR2T7 OR10Q1 OR2T1 OR11H6 OR3A2 OR6F1 OR52A5 OR7D2 OR2H2 | 8.48e-08 | 541 | 125 | 13 | 14983052 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 21849517 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 17906856 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 10873595 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 20635135 | ||
| Pubmed | 6.74e-07 | 46 | 125 | 5 | 32126975 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 1.99e-06 | 57 | 125 | 5 | 21886157 | |
| Pubmed | Maternal bile acid transporter deficiency promotes neonatal demise. | 2.37e-06 | 59 | 125 | 5 | 26416771 | |
| Pubmed | 3.75e-06 | 9 | 125 | 3 | 21264952 | ||
| Pubmed | 6.02e-06 | 190 | 125 | 7 | 24816252 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29357411 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20034614 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19429885 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23219238 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29944058 | ||
| Pubmed | SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome. | 1.28e-05 | 2 | 125 | 2 | 36964102 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11741895 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 37856781 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31467884 | ||
| Pubmed | Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide. | 1.28e-05 | 2 | 125 | 2 | 23340295 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29777022 | ||
| Pubmed | Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis. | 1.28e-05 | 2 | 125 | 2 | 26191226 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28887442 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24194513 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24855184 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20673332 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26474710 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25578040 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17936921 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24989890 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 14713302 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21719246 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20877131 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 16534140 | ||
| Pubmed | A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia. | 1.28e-05 | 2 | 125 | 2 | 15041036 | |
| Pubmed | Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. | 1.28e-05 | 2 | 125 | 2 | 18321482 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25617738 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 14993604 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18314419 | ||
| Pubmed | OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. | 1.28e-05 | 2 | 125 | 2 | 21691816 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22673578 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27642067 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28063966 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28493059 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22240838 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17412826 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26692285 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21266523 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12130747 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28108057 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22771883 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18180273 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 37723174 | ||
| Pubmed | Cytosolic phospholipase A2 is a key regulator of blood-brain barrier function in epilepsy. | 1.28e-05 | 2 | 125 | 2 | 31661303 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22369775 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28815335 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23670789 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21606417 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17496208 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23236639 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27098745 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24740327 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31299240 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23886114 | ||
| Pubmed | OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture. | 1.28e-05 | 2 | 125 | 2 | 21787759 | |
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 2.45e-05 | 16 | 125 | 3 | 19679677 | |
| Pubmed | 2.97e-05 | 17 | 125 | 3 | 19641107 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 3.35e-05 | 340 | 125 | 8 | 11875048 | |
| Pubmed | 3.35e-05 | 340 | 125 | 8 | 11802173 | ||
| Pubmed | Changes in thyroid status during perinatal development of MCT8-deficient male mice. | 3.56e-05 | 18 | 125 | 3 | 23696569 | |
| Pubmed | 3.57e-05 | 343 | 125 | 8 | 32295537 | ||
| Pubmed | 3.79e-05 | 346 | 125 | 8 | 14611657 | ||
| Pubmed | Direct identification of the agonist binding site in the human brain cholecystokininB receptor. | 3.84e-05 | 3 | 125 | 2 | 10320330 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 31047942 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 26146841 | ||
| Pubmed | MICA-A5.1 allele is associated with atypical forms of celiac disease in HLA-DQ2-negative patients. | 3.84e-05 | 3 | 125 | 2 | 11862400 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 23579063 | ||
| Pubmed | No association between the PPARG gene and schizophrenia in a British population. | 3.84e-05 | 3 | 125 | 2 | 19560328 | |
| Pubmed | MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ. | 3.84e-05 | 3 | 125 | 2 | 16698430 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 28704403 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 18296417 | ||
| Pubmed | Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. | 3.84e-05 | 3 | 125 | 2 | 18188595 | |
| Pubmed | Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations. | 3.84e-05 | 3 | 125 | 2 | 20660695 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 22136368 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 25578492 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 17178883 | ||
| Pubmed | Exposure to growth hormone is associated with hepatic up-regulation of cPLA2α and COX. | 3.84e-05 | 3 | 125 | 2 | 32259636 | |
| Interaction | MTX3 interactions | 4.55e-06 | 76 | 114 | 6 | int:MTX3 | |
| Interaction | ORMDL2 interactions | 1.61e-05 | 56 | 114 | 5 | int:ORMDL2 | |
| Interaction | SLCO1B3 interactions | 2.06e-05 | 10 | 114 | 3 | int:SLCO1B3 | |
| Interaction | ORMDL1 interactions | 3.87e-05 | 67 | 114 | 5 | int:ORMDL1 | |
| Cytoband | 1q44 | 1.34e-05 | 110 | 125 | 5 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 2.79e-05 | 128 | 125 | 5 | chr1q44 | |
| Cytoband | 1q25 | 4.89e-05 | 26 | 125 | 3 | 1q25 | |
| GeneFamily | Solute carriers | SLC2A9 SLC37A3 SLC16A9 SLCO2B1 SLC6A19 SLCO4A1 SLC26A9 SLCO1B3 SLC24A3 SLCO1B1 SLC39A13 SLC2A5 SLC5A5 SLC41A2 SLC17A5 SLC10A2 SLCO4C1 SLC16A5 SLC16A4 SLC41A3 SLC34A1 SLC18A1 SLCO2A1 SLC5A6 SLC22A4 SLC4A10 SLC49A3 SLC25A29 SLC16A7 SLC37A4 SLC16A10 | 1.34e-28 | 395 | 93 | 31 | 752 |
| GeneFamily | Guanylate cyclase receptors | 5.41e-04 | 7 | 93 | 2 | 343 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | SLCO1B3 SLCO1B1 SLC41A2 SLCO2A1 PKHD1 PLA2G4A SLC37A4 SLC16A10 | 3.13e-06 | 190 | 122 | 8 | MM1311 |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 1.31e-05 | 166 | 122 | 7 | M2398 | |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN | 3.69e-05 | 195 | 122 | 7 | M9309 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN | 4.06e-05 | 198 | 122 | 7 | M8723 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_DN | 4.33e-05 | 200 | 122 | 7 | M7786 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_1000 | ATP6V1A SLC16A9 HLA-DQB1 SLC6A19 PTGR2 SLC2A5 ADK SLC17A5 SLC10A2 SLCO4C1 SLC16A4 SLC34A1 SLC18A1 SLC22A4 PKHD1 SLC16A7 SLC37A4 | 3.03e-06 | 861 | 113 | 17 | gudmap_kidney_adult_RenalCortexMixed_Std_1000 |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_1000 | ATP6V1A HLA-DQB1 MFSD11 SLC6A19 PTGR2 SLC2A5 ADK RNF167 SLC10A2 TM9SF2 SLC16A4 SLC34A1 SLC18A1 SLC22A4 SLC37A4 | 3.47e-05 | 831 | 113 | 15 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_k1_1000 |
| CoexpressionAtlas | kidney | SLC2A9 SLC16A9 SLC6A19 SLC10A2 SLCO4C1 SLC16A4 SLC34A1 PKHD1 SLC37A4 | 5.82e-05 | 323 | 113 | 9 | kidney |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_top-relative-expression-ranked_1000 | ATP6V1A HLA-DQB1 MFSD11 SLC6A19 PTGR2 SLC2A5 ADK RNF167 SLC10A2 TM9SF2 SLC16A4 SLC34A1 SLC18A1 SLC22A4 SLC37A4 | 7.26e-05 | 887 | 113 | 15 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | ATP6V1A HLA-DQB1 SLC6A19 PTGR2 SLC2A5 SLC16A4 SLC34A1 SLC18A1 SLCO2A1 PKHD1 TM4SF1 SLC16A7 SLC37A4 SLC16A10 | 8.86e-05 | 799 | 113 | 14 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | ATP6V1A SLCO2B1 HLA-DQB1 MFSD11 ABCA9 SLC41A2 SLC17A5 SLC16A7 SOAT1 SLC16A10 | 1.07e-04 | 433 | 113 | 10 | GSM605856_500 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.27e-07 | 186 | 122 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-06 | 197 | 122 | 7 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-06 | 145 | 122 | 6 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 168 | 122 | 6 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.07e-05 | 181 | 122 | 6 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 185 | 122 | 6 | 3e3217c99719fd1d2fa94e16be7712a7e5077152 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 185 | 122 | 6 | 0ff4148b4701003d9d594e0da8261176fb13aa59 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-05 | 186 | 122 | 6 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 193 | 122 | 6 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 197 | 122 | 6 | 173c0c8de4e69882a9f91189deeb4a651fefe551 | |
| ToppCell | Epithelial_cells-Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.78e-05 | 198 | 122 | 6 | 52e9d41a1726bc1140df6baec9f17a534448ac8b | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-05 | 198 | 122 | 6 | 8d629492d2199de8e036c19e9dacceb9c9e721a0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 198 | 122 | 6 | a9d72b17adfddb6ac1857c5f094280e86582693b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 198 | 122 | 6 | b933bd66f544822fcf1f2aa2d928c31500e2b3f4 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-05 | 198 | 122 | 6 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.78e-05 | 198 | 122 | 6 | eeec789d226171f30799577cc37c07bdced2e3cb | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 199 | 122 | 6 | 4bde35e5df019189433d65d415e29a0c1145ac66 | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 199 | 122 | 6 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 199 | 122 | 6 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 1.89e-05 | 200 | 122 | 6 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.81e-05 | 144 | 122 | 5 | 3d880c140db4a0e7602bfddcb73a42a68c2848d5 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 145 | 122 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.97e-05 | 145 | 122 | 5 | e932361734839c14ffa0c1e028dcef9c833f884f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 5.13e-05 | 146 | 122 | 5 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 150 | 122 | 5 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.82e-05 | 155 | 122 | 5 | 15bacd06cc2b02b13c85bb71c5b758e5ff613e80 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-05 | 159 | 122 | 5 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-05 | 159 | 122 | 5 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 162 | 122 | 5 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.16e-05 | 165 | 122 | 5 | 60b500eb2c10cccf309b8fb28a9119da22d6889c | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 166 | 122 | 5 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 166 | 122 | 5 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 167 | 122 | 5 | 40d102e01ccbc7262d00fafd59ca5234909009cb | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.96e-05 | 168 | 122 | 5 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.14e-04 | 173 | 122 | 5 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 173 | 122 | 5 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.14e-04 | 173 | 122 | 5 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 174 | 122 | 5 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 174 | 122 | 5 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-04 | 176 | 122 | 5 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 177 | 122 | 5 | 201b0a8e6402a18aff0bb7c14f2bdd34fdf0db32 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 177 | 122 | 5 | 2a63288d09efd217b277aeecf957811a095f56e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 177 | 122 | 5 | 56fe389ffab73e3bc64f837b152d5907e3517a91 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 177 | 122 | 5 | d6596a0b6fd146fefc27717c1a7dbaa3774cc644 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 177 | 122 | 5 | 929cd8f530ce001623735da53b7278d02522e2b5 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 178 | 122 | 5 | e1e96a0e3ff718ebf676a982bc63e8ced6984059 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 178 | 122 | 5 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 122 | 5 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 178 | 122 | 5 | 363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 122 | 5 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 122 | 5 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 122 | 5 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-04 | 179 | 122 | 5 | 3d3716078afdb9a89ddfadb3197cd1b52fa770be | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 180 | 122 | 5 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-04 | 181 | 122 | 5 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | severe_influenza-B_intermediate|World / disease group, cell group and cell class (v2) | 1.45e-04 | 182 | 122 | 5 | e633a908a2fb30ed362cf22fbb8d6839f31f1751 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 183 | 122 | 5 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.49e-04 | 183 | 122 | 5 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 183 | 122 | 5 | 824ecda1219fb596a01bf5cfeee29a6daa462098 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 183 | 122 | 5 | 82b84ee065fb573688d59da97a327152a1ba294c | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.53e-04 | 184 | 122 | 5 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 184 | 122 | 5 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 185 | 122 | 5 | 53854a9ec87c24c360541c83d86d8fafb303ad58 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 185 | 122 | 5 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 185 | 122 | 5 | a61fc7a3700a1efcf640bef7680c0443ee148a46 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 185 | 122 | 5 | dc59b8dc459a3c444c9634a0d438cbef54c40036 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.56e-04 | 185 | 122 | 5 | 53960307c6710401c3d52a766c3f4704ace9637f | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 186 | 122 | 5 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-04 | 186 | 122 | 5 | e4de270d38bbed022f545bd0bbaa9599e707ec87 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 186 | 122 | 5 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-04 | 187 | 122 | 5 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 187 | 122 | 5 | ed69e7cbd6fb59363b0e26f24887fc49405397ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 187 | 122 | 5 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-04 | 187 | 122 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.69e-04 | 188 | 122 | 5 | ef05d2fb17fd427d46d454e67073e0e1b45bb24c | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.69e-04 | 188 | 122 | 5 | e5ab89030783461e9367ab87c353fb5c31911020 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.69e-04 | 188 | 122 | 5 | 13653481d64c7a1ad833d738a3ee0bb9def7cec7 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 188 | 122 | 5 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.73e-04 | 189 | 122 | 5 | ebaf722738c71d5f33f72341f801c6880f4aee14 | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 189 | 122 | 5 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-04 | 190 | 122 | 5 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-04 | 190 | 122 | 5 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-04 | 191 | 122 | 5 | a4200717672e2358eb649eae2553f293b4fd8f7e | |
| ToppCell | facs-Brain_Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 191 | 122 | 5 | bf1135b382a3bf8cddc19538bc38361ef1fc2de1 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 1.81e-04 | 191 | 122 | 5 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.86e-04 | 192 | 122 | 5 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.86e-04 | 192 | 122 | 5 | 24797e80b1f5b3ea5a0410caaf57ccf2ae9d716e | |
| ToppCell | Control-B_intermediate-10|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.86e-04 | 192 | 122 | 5 | 224bd958369ba8fa0d7be2126f7dc61c9f6ac19d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.86e-04 | 192 | 122 | 5 | 4037b4c4fbb40541b8c424c36d3871a57891b8dd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.86e-04 | 192 | 122 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 192 | 122 | 5 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 193 | 122 | 5 | f92bbe70e6c725bfb8c08bfc2a94e375528151a3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.90e-04 | 193 | 122 | 5 | fc2eb6a7b4f1e687bf37e59e3cd52b14f99ffea4 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-04 | 193 | 122 | 5 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.90e-04 | 193 | 122 | 5 | 79a95ac4f46abee00e03700c10cdb00c4507ea76 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 193 | 122 | 5 | 44ba79db566d0fa3bbcfe3adf9164bf8c3cb0bc3 | |
| ToppCell | Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.90e-04 | 193 | 122 | 5 | 642f8f20e5a35a4b5d1fc8d3f1e3b9b83a37a654 | |
| ToppCell | ileum-Absorptive_Enterocytes|ileum / shred on tissue and cell subclass | 1.92e-04 | 41 | 122 | 3 | 650cec538c6acd92f45d804b3c94248c6231aa21 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 194 | 122 | 5 | cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-04 | 194 | 122 | 5 | b8f05efb16fbed7317019efc3da7f97f81e90972 | |
| Computational | Genes in the cancer module 162. | 1.56e-07 | 19 | 75 | 5 | MODULE_162 | |
| Computational | Genes in the cancer module 218. | 9.73e-06 | 20 | 75 | 4 | MODULE_218 | |
| Computational | Genes in the cancer module 71. | 1.45e-05 | 22 | 75 | 4 | MODULE_71 | |
| Computational | Peptide and AA transporters. | 2.47e-04 | 18 | 75 | 3 | MODULE_368 | |
| Drug | sulfinpyrazone | SLC16A9 SLCO2B1 SLCO4A1 SLCO1B3 SLCO1B1 PTGS2 SLC2A5 SLC17A5 SLC10A2 SLCO4C1 SLCO2A1 SLC16A7 | 3.69e-14 | 87 | 121 | 12 | CID000005342 |
| Drug | cimetidine | SLC16A9 SLCO2B1 SLCO4A1 SLCO1B3 SLCO1B1 PTGS2 CCKBR SLC17A5 SLC10A2 SLCO4C1 SLCO2A1 SLC22A4 SLC16A7 | 1.33e-11 | 179 | 121 | 13 | CID000002756 |
| Drug | probenecid | SLC16A9 SLCO2B1 SLCO4A1 SLCO1B3 SLCO1B1 SLC17A5 SLC10A2 SLCO4C1 SLC16A5 SLCO2A1 SLC16A7 | 5.62e-11 | 123 | 121 | 11 | CID000004911 |
| Drug | Digocin | 3.61e-09 | 70 | 121 | 8 | CID000003062 | |
| Drug | 17beta-estradiol glucuronide | 1.61e-08 | 32 | 121 | 6 | CID000066424 | |
| Drug | NSC 117356 | SLC16A9 SLCO2B1 SLCO4A1 SLCO1B3 LBR SLCO1B1 SLC17A5 SLC10A2 SLCO4C1 SLCO2A1 SLC16A7 | 8.41e-08 | 246 | 121 | 11 | CID000004112 |
| Drug | sodium cholate | SLCO2B1 SLCO4A1 SLCO1B3 APOL1 SLCO1B1 PTGS2 CCKBR TGFA HSD3B7 SLC10A2 SLC34A1 SLC22A4 SOAT1 | 2.77e-07 | 408 | 121 | 13 | CID000000303 |
| Drug | sodium | ATP6V1A SLC2A9 ANK2 SLCO2B1 ARL6IP5 SLCO4A1 OR2T1 SLC26A9 SLCO1B3 SLC24A3 SLCO1B1 SLC2A5 SLC5A5 SLC10A2 SLC34A1 SLC18A1 SLC5A6 SLC22A4 SLC16A10 | 5.77e-07 | 944 | 121 | 19 | CID000000923 |
| Drug | Dihydromicrocystin Lr | 5.83e-07 | 4 | 121 | 3 | CID006441227 | |
| Drug | 15-ketoprostaglandin E2 | 9.90e-07 | 15 | 121 | 4 | CID000001441 | |
| Drug | 2,2',4,4',5,6'-hexabromodiphenyl ether | 1.45e-06 | 5 | 121 | 3 | ctd:C555859 | |
| Drug | Oxycodone | SLCO1B3 SLC41A2 SLC17A5 SLC10A2 PLA2G4A SLC25A29 SLC37A4 SLC16A10 | 1.64e-06 | 153 | 121 | 8 | ctd:D010098 |
| Drug | prednisolone phosphate | 2.89e-06 | 6 | 121 | 3 | CID000004896 | |
| Drug | BQ 123 | 4.49e-06 | 46 | 121 | 5 | CID000123632 | |
| Drug | lumiracoxib | 5.05e-06 | 7 | 121 | 3 | ctd:C473384 | |
| Drug | nateglinide | 5.05e-06 | 7 | 121 | 3 | ctd:C060142 | |
| Drug | AC1L1KSK | 6.22e-06 | 23 | 121 | 4 | CID000005636 | |
| Drug | NSC263652 | 8.04e-06 | 8 | 121 | 3 | CID000429721 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 1.20e-05 | 9 | 121 | 3 | ctd:C000588958 | |
| Drug | tariquidar | 1.21e-05 | 27 | 121 | 4 | CID000148201 | |
| Drug | sulfobromophthalein | 1.87e-05 | 103 | 121 | 6 | CID000005345 | |
| Drug | Rutin | 2.08e-05 | 105 | 121 | 6 | ctd:D012431 | |
| Drug | repaglinide | 2.34e-05 | 11 | 121 | 3 | ctd:C072379 | |
| Drug | NSC740136 | 2.58e-05 | 109 | 121 | 6 | CID000003706 | |
| Drug | 3-iodothyronamine | 2.76e-05 | 33 | 121 | 4 | ctd:C487948 | |
| Drug | SQ 33,552 | 2.80e-05 | 2 | 121 | 2 | CID009576908 | |
| Drug | SQ 33,261 | 2.80e-05 | 2 | 121 | 2 | CID009576907 | |
| Drug | prostaglandin F1 | 2.80e-05 | 2 | 121 | 2 | ctd:C100006 | |
| Drug | (5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid | 2.80e-05 | 2 | 121 | 2 | ctd:C561635 | |
| Drug | glimepiride | 3.11e-05 | 12 | 121 | 3 | ctd:C057619 | |
| Drug | AH23848B | 3.50e-05 | 35 | 121 | 4 | CID005310999 | |
| Drug | 1,2,5,6-dibenzanthracene | TBXA2R TMEM88 SLC2A9 SLCO2B1 VASN DDIAS HHIP RNF167 SLC10A2 SLC16A5 NRXN1 PTGR1 SLC5A6 SLC16A7 HYDIN | 3.84e-05 | 837 | 121 | 15 | ctd:C026486 |
| Drug | Cholic Acid | 5.00e-05 | 75 | 121 | 5 | ctd:D019826 | |
| Drug | Pyruvic acid | 5.11e-05 | 14 | 121 | 3 | DB00119 | |
| Drug | Biotin | 6.36e-05 | 15 | 121 | 3 | ctd:D001710 | |
| Drug | Budesonide | 6.82e-05 | 80 | 121 | 5 | ctd:D019819 | |
| Drug | Octopamina | 8.37e-05 | 3 | 121 | 2 | CID005311213 | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 6068_UP | |
| Drug | DDDs | 9.43e-05 | 17 | 121 | 3 | CID000014360 | |
| Drug | vinylidene chloride | NPR2 ANK2 SLC16A9 ACTR10 SLC6A19 SLCO4A1 PTGR2 ADGRL1 DDIAS SLC10A2 SLCO4C1 SLC16A5 PTGR1 SLC34A1 SLC18A1 SLC22A4 TM4SF1 MVP SLC16A7 SOAT1 | 9.71e-05 | 1475 | 121 | 20 | ctd:C029297 |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 9.85e-05 | 200 | 121 | 7 | 3833_UP | |
| Drug | chloride | ATP6V1A NPR2 SLC26A9 LBR APOL1 PTGS2 TGFA SLC5A5 ADK PTGR1 SLC34A1 SLC18A1 SLC5A6 PLA2G4A SOAT1 SLC16A10 | 1.12e-04 | 1029 | 121 | 16 | CID000000312 |
| Drug | flunixin | 1.13e-04 | 18 | 121 | 3 | CID000038081 | |
| Drug | 3alpha, 7beta-dihydroxy-5beta-cholan-24-oic acid | 1.18e-04 | 206 | 121 | 7 | CID000005645 | |
| Drug | Mirex | 1.23e-04 | 48 | 121 | 4 | ctd:D008917 | |
| Drug | pentabromodiphenyl ether | CMKLR2 ATP6V1A SLCO2B1 SLC6A19 SLCO1B3 SLCO1B1 TMEM132B PTGS2 SLC5A5 SLC41A2 SLC17A5 HSD3B7 PTGR1 OR7D2 TLR5 PLA2G4A SLC16A7 SLC16A10 | 1.26e-04 | 1266 | 121 | 18 | ctd:C086401 |
| Drug | hydride | DOCK3 ATP6V1A NPR2 STAG1 SLC26A9 LBR HSD3B7 PTGR1 SLC34A1 SLC18A1 GUCY2D SLC16A7 SOAT1 SDHC | 1.43e-04 | 835 | 121 | 14 | CID000000783 |
| Drug | polydatin | 1.45e-04 | 50 | 121 | 4 | ctd:C058229 | |
| Drug | black widow spider venom | 1.67e-04 | 4 | 121 | 2 | ctd:C038599 | |
| Drug | alpha-latrotoxin | 1.67e-04 | 4 | 121 | 2 | ctd:C020763 | |
| Drug | rifamycin SV | 1.67e-04 | 4 | 121 | 2 | ctd:C023808 | |
| Drug | microcystin-LF | 1.67e-04 | 4 | 121 | 2 | ctd:C524165 | |
| Drug | latanoprost | 1.67e-04 | 4 | 121 | 2 | ctd:C072042 | |
| Drug | Niflumic Acid | 1.67e-04 | 4 | 121 | 2 | DB04552 | |
| Drug | Taurocholic Acid | 1.79e-04 | 98 | 121 | 5 | ctd:D013656 | |
| Disease | uric acid measurement | SLC2A9 SLC16A9 HLA-DQB1 ARL6IP5 PTGR2 SLCO1B1 SLC10A2 SLC22A4 GUCY2D HERC4 SOAT1 SLC16A10 | 4.05e-06 | 610 | 113 | 12 | EFO_0004761 |
| Disease | arachidonoylcarnitine (C20:4) measurement | 1.17e-05 | 12 | 113 | 3 | EFO_0800544 | |
| Disease | glycolithocholate sulfate measurement | 1.45e-05 | 2 | 113 | 2 | EFO_0800258 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC | 1.45e-05 | 2 | 113 | 2 | C4016905 | |
| Disease | Rotor Syndrome | 1.45e-05 | 2 | 113 | 2 | C0220991 | |
| Disease | Rotor syndrome | 1.45e-05 | 2 | 113 | 2 | cv:C0220991 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE | 1.45e-05 | 2 | 113 | 2 | 237450 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 1.52e-05 | 13 | 113 | 3 | EFO_0800547 | |
| Disease | taurolithocholate 3-sulfate measurement | 1.52e-05 | 13 | 113 | 3 | EFO_0021036 | |
| Disease | Glycodeoxycholate sulfate measurement | 4.35e-05 | 3 | 113 | 2 | EFO_0022098 | |
| Disease | non-melanoma skin carcinoma | 7.48e-05 | 265 | 113 | 7 | EFO_0009260 | |
| Disease | longitudinal BMI measurement, non-small cell lung carcinoma | 8.68e-05 | 4 | 113 | 2 | EFO_0003060, EFO_0005937 | |
| Disease | pancreatic cancer (implicated_via_orthology) | 8.68e-05 | 4 | 113 | 2 | DOID:1793 (implicated_via_orthology) | |
| Disease | taurodeoxycholic acid 3-sulfate measurement | 8.68e-05 | 4 | 113 | 2 | EFO_0800386 | |
| Disease | glycodeoxycholate 3-sulfate measurement | 8.68e-05 | 4 | 113 | 2 | EFO_0800385 | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 1.44e-04 | 5 | 113 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | urate measurement | DOCK3 SLC2A9 SLC16A9 HLA-DQB1 ARL6IP5 SLCO1B1 NRXN1 TGFBRAP1 PKHD1 PLA2G4A HERC4 SLC16A10 | 1.68e-04 | 895 | 113 | 12 | EFO_0004531 |
| Disease | MHC class I polypeptide-related sequence B measurement | 2.06e-04 | 30 | 113 | 3 | EFO_0008234 | |
| Disease | Curling Ulcer | 2.16e-04 | 6 | 113 | 2 | C0010474 | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 2.16e-04 | 6 | 113 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | Duodenal Ulcer | 2.16e-04 | 6 | 113 | 2 | C0013295 | |
| Disease | taurocholenate sulfate measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0800277 | |
| Disease | excessive daytime sleepiness measurement | 2.74e-04 | 33 | 113 | 3 | EFO_0007875 | |
| Disease | Thyroid Gland Follicular Adenoma | 3.27e-04 | 35 | 113 | 3 | C0151468 | |
| Disease | Thyroid Neoplasm | 3.86e-04 | 37 | 113 | 3 | C0040136 | |
| Disease | deoxycholic acid glucuronide measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0800575 | |
| Disease | acetylcarnitine measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0021038 | |
| Disease | butyrylcarnitine measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0020010 | |
| Disease | Cognition Disorders | 4.18e-04 | 38 | 113 | 3 | C0009241 | |
| Disease | lung cancer (implicated_via_orthology) | 5.14e-04 | 9 | 113 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | X-11381 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0021228 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0800562 | |
| Disease | liver cancer (is_marker_for) | 5.14e-04 | 9 | 113 | 2 | DOID:3571 (is_marker_for) | |
| Disease | X-21467 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0020007 | |
| Disease | Asthma, Occupational | 6.41e-04 | 10 | 113 | 2 | C0264423 | |
| Disease | cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 | 6.41e-04 | 10 | 113 | 2 | EFO_0001061, EFO_1000166 | |
| Disease | Thyroid carcinoma | 6.46e-04 | 44 | 113 | 3 | C0549473 | |
| Disease | sleep duration, triglyceride measurement | 6.98e-04 | 104 | 113 | 4 | EFO_0004530, EFO_0005271 | |
| Disease | tyrosine measurement | 6.98e-04 | 104 | 113 | 4 | EFO_0005058 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 7.82e-04 | 11 | 113 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 7.82e-04 | 11 | 113 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | pneumonia | 7.84e-04 | 47 | 113 | 3 | EFO_0003106 | |
| Disease | hexanoylcarnitine measurement | 9.36e-04 | 12 | 113 | 2 | EFO_0021040 | |
| Disease | Papilloma | 9.36e-04 | 12 | 113 | 2 | C0030354 | |
| Disease | Papillomatosis | 9.36e-04 | 12 | 113 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 9.36e-04 | 12 | 113 | 2 | C0205874 | |
| Disease | cerotoylcarnitine (C26) measurement | 1.10e-03 | 13 | 113 | 2 | EFO_0800542 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.10e-03 | 13 | 113 | 2 | EFO_0800474 | |
| Disease | Asthma, Aspirin-Induced | 1.10e-03 | 13 | 113 | 2 | C1319853 | |
| Disease | age at menopause | 1.11e-03 | 302 | 113 | 6 | EFO_0004704 | |
| Disease | testosterone measurement | DOCK3 ANK2 SLC16A9 STAG1 SLCO1B3 SLC24A3 SLCO1B1 NRXN1 SLC34A1 TGFBRAP1 MYO15A HERC4 SOAT1 | 1.20e-03 | 1275 | 113 | 13 | EFO_0004908 |
| Disease | asymmetric dimethylarginine measurement | 1.28e-03 | 14 | 113 | 2 | EFO_0010463 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 1.45e-03 | 58 | 113 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | amyotrophic lateral sclerosis, age at onset | 1.48e-03 | 15 | 113 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | Blood Platelet Disorders | 1.68e-03 | 16 | 113 | 2 | C0005818 | |
| Disease | sarcoidosis (is_implicated_in) | 1.68e-03 | 16 | 113 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | Dermatitis | 1.68e-03 | 16 | 113 | 2 | C0011603 | |
| Disease | total blood protein measurement | 1.75e-03 | 449 | 113 | 7 | EFO_0004536 | |
| Disease | cystic fibrosis (is_marker_for) | 1.75e-03 | 62 | 113 | 3 | DOID:1485 (is_marker_for) | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 1.90e-03 | 17 | 113 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | Graves disease, thyrotoxic periodic paralysis | 1.90e-03 | 17 | 113 | 2 | EFO_0004237, MONDO_0019201 | |
| Disease | Profound Mental Retardation | 2.04e-03 | 139 | 113 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.04e-03 | 139 | 113 | 4 | C0025363 | |
| Disease | Mental deficiency | 2.04e-03 | 139 | 113 | 4 | C0917816 | |
| Disease | Oral Submucous Fibrosis | 2.14e-03 | 18 | 113 | 2 | C0029172 | |
| Disease | melanoma | 2.71e-03 | 248 | 113 | 5 | C0025202 | |
| Disease | Autoimmune Hepatitis | 2.91e-03 | 21 | 113 | 2 | EFO_0005676 | |
| Disease | HbA1c measurement, response to sulfonylurea | 2.91e-03 | 21 | 113 | 2 | EFO_0004541, EFO_0007922 | |
| Disease | response to angiotensin-converting enzyme inhibitor | 3.38e-03 | 78 | 113 | 3 | EFO_0005325 | |
| Disease | Liver carcinoma | 3.43e-03 | 507 | 113 | 7 | C2239176 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.80e-03 | 24 | 113 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.80e-03 | 24 | 113 | 2 | C3805278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFGMGNPLLDISAVV | 26 | P55263 | |
| FGTMLIPPFTLIGSL | 1166 | Q8IUA7 | |
| FNMEFLGPCGLRLVG | 271 | Q9H2F3 | |
| ATQGLSRAGLPFGLM | 21 | O94910 | |
| FGVELGPSLMNLIAG | 321 | P20594 | |
| TLLPNLMGTFIFGTV | 111 | P32239 | |
| LFIFLMPLPGVFGGI | 11 | O15263 | |
| SMGSPFLLAGLIGGA | 536 | O43155 | |
| LLSFMGLFICGETPG | 166 | P0CG01 | |
| ENLVVIGGTSMLPGF | 301 | Q9NZ32 | |
| MGGLGFIILDRSNAP | 96 | Q9NRP0 | |
| FLGGGEGLLLVVMAF | 106 | A0A096LPK9 | |
| FILLGFTTDPGMQLG | 11 | Q8NH87 | |
| GVPGVFLIMFGLPVF | 211 | Q14739 | |
| MGLGPVFLLLAGIFP | 1 | Q29983 | |
| VMLNGFGGDAPTLRL | 1246 | Q01484 | |
| GLVELGFILMDSYGP | 381 | Q9NVI1 | |
| GVAFSLGFTLGPMLG | 181 | Q14728 | |
| MFFAGLGNSLGPPIV | 436 | Q7RTY1 | |
| TGGLDLIFMPGLGFD | 126 | P49914 | |
| NSMIIFGPFLSILGS | 221 | Q8NGC7 | |
| MVNQSSTPGFLLLGF | 1 | O95918 | |
| GGSLDGFLLTPITMS | 201 | O43869 | |
| FLGLGLSGVVPTMHF | 271 | Q96A54 | |
| SDGGGFPLSGLLMVL | 191 | A8MXT2 | |
| TILEFNLFGIPMVGA | 591 | Q2M2H8 | |
| VFLGFLLVVGMGLAG | 466 | Q02846 | |
| RAQFLGLLSALPMFG | 3401 | Q9UKN7 | |
| LGGSIDGFLLTPVTM | 141 | P0C7T2 | |
| LLLFAVGFIMAGTPL | 206 | P47893 | |
| GSVFMPSAFILIGIP | 6 | Q9H2C5 | |
| FLGGGEGLLLVVMAF | 106 | Q8NGD1 | |
| FLGGGEGLLLVVMAF | 106 | Q8N0Y3 | |
| AQFIGPLVFGGMNLT | 176 | Q9H2J4 | |
| KIFPSDMLGFQGIGL | 871 | Q8IXT1 | |
| SLLGIPFMQVAAGGA | 186 | Q5GLZ8 | |
| DPAPGFSMLLFGVSL | 96 | O14511 | |
| MGFITGLGLAFNLQP | 116 | O60669 | |
| FAVGQEVFGLVPGLM | 271 | P35354 | |
| ILPGILNDTLRFGMF | 301 | Q2TBA0 | |
| DMTVFSGLFVGGLPP | 146 | Q9ULB1 | |
| GGSIDGFLLTPVTMQ | 151 | Q8NH04 | |
| FILLGFTTDPGMQLG | 11 | P0C7N8 | |
| AIVGPQLSMFASGLF | 71 | O43934 | |
| MTIGFALQLLGGPFQ | 26 | Q96RP7 | |
| INPGLFIMTPAGVFL | 216 | Q7LFL8 | |
| FGPAGIGLLIMGFLV | 546 | Q02413 | |
| LFNTAFGLLGMGPEG | 841 | Q14764 | |
| GIPDVIMGITFLAAG | 506 | Q9HC58 | |
| MVGVGTPFGALLAFV | 541 | Q06495 | |
| LMANVGGFLAGLPFS | 371 | O43826 | |
| MLSGIGGFVLGLIFL | 231 | P01920 | |
| SSLAGGEYIIPLFGM | 5006 | Q4G0P3 | |
| FIPGMIGPFLGVTLV | 1091 | Q8IZD9 | |
| PLTGLVGFPAGFATM | 2491 | Q8TD26 | |
| MTEGVLPGLYLGNFI | 1 | Q9H1R2 | |
| GVSLFGMSALLLPGN | 81 | Q99643 | |
| SGILTLVGMGLAPFT | 186 | O14791 | |
| LVGMGLAPFTEGGSL | 191 | O14791 | |
| GLGSPLMGLTFINAL | 61 | Q8N8R3 | |
| GFPPQTATGTLMLFL | 476 | Q8IXH8 | |
| RPLLIGGFGLMGLFF | 381 | Q9NRM0 | |
| LFLTLLDMAQGFRGP | 11 | Q12794 | |
| FLVILLPSGKGMFGN | 11 | Q30KP8 | |
| MLPAGGILVFLTGQA | 466 | Q8IY37 | |
| GMIGPAVFLVAAGFI | 371 | Q9NRA2 | |
| LGITNTFATIPGMVG | 426 | Q9NRA2 | |
| GILTLFFPESLGMTL | 501 | Q9H015 | |
| SLLGSLMVGLSGVFP | 71 | Q96H72 | |
| GVGLLELGFMTLSIF | 251 | P11049 | |
| GFPGSQTLQLSLFML | 16 | Q8NGZ6 | |
| TVGMPGLTAYFGLLE | 121 | Q14914 | |
| GFLCQFGIMPLTGFI | 71 | Q12908 | |
| GQPVTFTDIFGMLIG | 286 | P47712 | |
| TQMLGGALGLALFPS | 146 | Q8NGQ4 | |
| IMLFLTTGLFAALGP | 246 | A6ND48 | |
| ALPGGIILMELAFQG | 2986 | Q5T011 | |
| GGGAFMIPFLILLVL | 66 | Q695T7 | |
| LFMIFQIGVLGFGPT | 226 | P35610 | |
| IPALLGGTTMELFFT | 206 | Q14DG7 | |
| LLGPVIMGVGLFVFI | 116 | Q69YZ2 | |
| KVFGPLIMGIGIFLF | 166 | A6NKL6 | |
| GGSIQVPQGMAFALL | 81 | Q7LBE3 | |
| GPVLQAAISIFGMVG | 421 | Q9Y289 | |
| AAISIFGMVGGPLLG | 426 | Q9Y289 | |
| SMFPFGGFIGSLLVG | 76 | P22732 | |
| SIVGFLSPFNMILGG | 56 | O75915 | |
| PFTGIVGLLVLAMGA | 176 | Q9H6Y7 | |
| AGPAFMQFLTLLGDV | 356 | Q96FS4 | |
| AFTLIGLPFNNGLMG | 281 | Q11203 | |
| GMAFALLASVPPVFG | 41 | Q8NG04 | |
| PFLLAGFGTVSAGMV | 166 | Q96JW4 | |
| GLQVTVPFMFAGLGL | 66 | Q96GZ6 | |
| FMTGVLGVFPLLGII | 201 | Q96RA2 | |
| GVFLGPIFGDMLATA | 886 | P08F94 | |
| ITGMLEFSLFGIPLV | 616 | P14410 | |
| FRGGMLTNARLLFGP | 171 | Q9Y399 | |
| PDGFLYIILGDGMIT | 361 | Q96QV1 | |
| AMIGPIIGFTLGSLF | 216 | Q9Y6L6 | |
| GVLLMGTGSLVFALP | 176 | Q96BD0 | |
| VMQAGIPLSTGLAFL | 281 | P46091 | |
| GLFGFSVGPVAMELA | 351 | Q6UXD7 | |
| VNLPAAALGMLFGGI | 371 | Q92959 | |
| MVPSAGQLALFALGI | 1 | P01135 | |
| FLLAGPGGLGMFATV | 221 | Q8WUH2 | |
| TMGLLPGLGSAFLYQ | 116 | O15374 | |
| GFSNIFLRPLAGLMA | 281 | O15375 | |
| LLMTVTGFFIGGPSN | 386 | Q8NCC5 | |
| SFTVMGVISGPLLGA | 416 | Q92911 | |
| GVISGPLLGAFILGM | 421 | Q92911 | |
| IMFVAQTLLGVGGVP | 191 | O94956 | |
| VISLDGFFMLLFPGT | 61 | Q9NYW1 | |
| ASQGGLGMYETPLFL | 2186 | P12270 | |
| MIGLGALVFSLPQFF | 181 | Q6ZQN7 | |
| ALLGTPVGGLLMAFQ | 196 | Q9NPL8 | |
| MLLTLAGGALFFPGL | 1 | Q8TBR7 | |
| MSPVITFGGLLGEAT | 521 | Q6U841 | |
| SLNAIGMIGPVIGFA | 211 | Q9NPD5 | |
| GMIGPVIGFALGSLF | 216 | Q9NPD5 | |
| LMTGGREGLQPLVFN | 806 | Q8WVM7 | |
| GTILLPAVTMLGFGF | 51 | Q6PEY1 | |
| LSVELGPGIMGAIFD | 86 | P38606 | |
| SGIVGGGLLMLLPAF | 51 | P30408 | |
| MLDAGSFAGLPGLQL | 66 | Q6EMK4 | |
| MGGILPFGCIFIQLF | 526 | Q99805 | |
| VMIFFGLSPLLLGAA | 111 | P21731 | |
| DLLLGVVLMAGPVFG | 6 | O60602 | |
| LSYFLGAIGMPGLTS | 126 | Q8N8N7 | |
| TVFMLFSGQGSLLQP | 171 | P57088 | |
| LALGLLVGAPFGSVM | 236 | P54219 | |
| VSQAIGFLLGFMSIP | 416 | Q8TF71 |